DrugPatentWatch Database Preview
MYDAYIS Drug Profile
Which patents cover Mydayis, and when can generic versions of Mydayis launch?
Mydayis is a drug marketed by Shire Dev Llc and is included in one NDA. There are five patents protecting this drug and two Paragraph IV challenges.
This drug has forty-three patent family members in thirty countries.
The generic ingredient in MYDAYIS is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. There are fifty-four drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.
Summary for MYDAYIS
| International Patents: | 43 |
| US Patents: | 5 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for MYDAYIS |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for MYDAYIS |
| DailyMed Link: | MYDAYIS at DailyMed |
US Patents and Regulatory Information for MYDAYIS
Expired US Patents for MYDAYIS
Paragraph IV (Patent) Challenges for MYDAYIS
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 37.5 mg and50 mg | ➤ Subscribe | ➤ Try a Free Trial |
| ➤ Subscribe | Extended-release Capsules | 12.5 mg and 25 mg | ➤ Subscribe | ➤ Try a Free Trial |
International Patents for MYDAYIS
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Spain | 2360046 | ➤ Try a Free Trial |
| European Patent Office | 1977736 | ➤ Try a Free Trial |
| Mexico | PA05003129 | ➤ Try a Free Trial |
| Norway | 20051986 | ➤ Try a Free Trial |
| African Intellectual Property Organization (OAPI) | 13075 | ➤ Try a Free Trial |
| Canada | 2348090 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
